Thursday , 5 December 2024
Home Health Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Health

Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity

This policy watch examines the implications of new proposed regulations that would allow Medicare and require Medicaid to cover drugs used to treat obesity, including a relatively new class of highly effective but costly drugs known as GLP-1s.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Video: Battle of the Bulge – Wegovy vs. Zepbound

The GLP-1 battle heats up with new preliminary data from Eli Lilly...

Bowel Cancer vs Colon Cancer: A Guide to Awareness and Prevention

Bowel cancer vs colon cancer are two common types of cancer that...

Lyle Berkowitz is an old friend and these days is CEO of...

That is the title of an interview with me in The Evidence...